Economic impact of respiratory syncytial virus-related illness in the US: an analysis of national databases.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

To determine the impact of respiratory syncytial virus (RSV) infection on healthcare resource use and costs in the US from the third-party payer perspective.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Pharmacoeconomics

Title: PharmacoEconomics

Publisher: Springer Science and Business Media LLC

ISSN: 1170-7690

ISSN (Print): 1170-7690

Publication date (Electronic): 2004

Volume: 22

Issue: 5

Affiliations

[1 ] MEDTAP International Inc., Bethesda, Maryland 20814, USA. paramore@medtap.com

Article

Publisher Item ID: 2251

DOI: 10.2165/00019053-200422050-00001

PubMed ID: 15061677

SO-VID: d3305484-fd80-4549-8e80-416789b484e1

History

Data availability:

Comments

Comment on this article

scite_

0

Smart Citations

0

Citing PublicationsSupportingMentioningContrasting

View Citations

See how this article has been cited at scite.ai

scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.